Jury sides with Axonics in Medtronic patent dispute

A California jury ruled on Wednesday that Axonics did not infringe three of Medtronic’s patents related to sacral neuromodulation.
The latest decision resolves a lawsuit that has been ongoing since 2019. In the ensuing battle, Axonics challenged the validity of Medtronic’s patents. Medtronic filed additional complaints in Delaware and with the U.S. International Trade Commission, seeking to block sales of Axonics’ devices.